Increased risk of cardiovascular disease in newly diagnosed Type 2 diabetic patients in a primary health care center in Trinidad

Diabetes Research and Clinical Practice

Volumn 50, Issue 2, 2000, Pages 137-145

  Ezenwaka, C E ^a   Davis, G ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Cardiovascular disease; Prevalence; Type 2 diabetes

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIMARY HEALTH CARE; RISK FACTOR; TREATMENT PLANNING;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMMUNITY HEALTH CENTERS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; MORBIDITY; OBESITY; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS; TRINIDAD AND TOBAGO;

EID: 0034308155     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00165-0     Document Type: Article

References (38)

1. Olefsky L.M., Kolterman O.G., Scarlett J.A. Insulin action and resistance in obesity and NIDDM. Am. J. Physiol. 243:1982;15-30.
2. DeFronzo R.A., Simmonsort D., Ferrannini E. Hepatic and peripheral insulin resistance a common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin dependent) diabetes mellitus. Diabetologia. 23:1982;313-319.
3. Newman B., Selby J.V., King M.C. et al. Concordance for Type 2 (NIDDM) diabetes in male twins. Diabetologia. 23:1987;763-768.
4. A.H. Bamett, C. Effo, R.D. Leslie, D.A. Pyke, Diabetes in identical twins a study of 200 pairs, Diabetologia 20 (1981) 87-93.
5. B.O. Osuntokun, F.M. Akinkugbe, T.I. Francis, S. Reddy, O. Osuntokun, G.O.L. Taylor, Diabetes mellitus in Nigerians: a study of 832 patients, W. Afr. Med. J. 20 (1971) 295-312.
6. UKPDS, Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. Lancet 352 (1998) 837-853.
7. Manton K.G. The global impact of non-communicable diseases: estimates and projections. World Health Stat. Quart. 41:1988;255-266.
8. Liu L.S. Epidemiology of hypertension and cardiovascular disease - China experience. Clin. Exp. Hypertens. Part A, Theory Pract. 12(5):1990;831-844.
9. Ezenwaka C.E., Akanji A.O., Akanji B.O. et al. The prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly southwestern Nigerians. Atherosclerosis. 128:1997;201-211.
10. Campos H., Mata L., Sila X. et al. Prevalence of cardiovascular risk factors in rural and urban Costa Rica. Circulation. 85:1992;648-658.
11. Ramirez E.A. Cardiovascular health in Puerto Ricans compared to other population groups in the US. Ethn. Dis. 1(2):1991;188-199.
12. Garcia-Palmieri M.R., Sorlier P.D., Havlik M. et al. Urban-rural differences in 12 year coronary heart disease mortality: the Puerto Rico Heart Program. J. Clin. Epidemiol. 41(3):1988;285-291.
13. Reaven G.M. Role of insulin in human disease. Diabetes. 37:1988;1595-1607.
14. DeFronzo R.A., Ferannini E. Insulin resistance a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atheroscierotic vascular disease. Diab. Care. 18:1991;173-194.
15. Hypertension detection and Follow-up Programme Cooperative Group, Blood pressure studies in 14 communities: a two stage screen for hypertension, JAMA 237 (1977) 2385-2391.
16. The Expert Panel, Report of the National Cholesterol Education Programme, Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults, Arch. Intern. Med. 148 (1988) 36-69.
17. World Health Organization, Arterial hypertension, Report of a World Health Organization Expert Committee 628 (1978).
18. World Health Organization Working Group, Use and interpretation of anthropometric indicators of nutritional status, Bull. WHO 64 (6) (1986) 929-941.
19. United Kingdom Prospective Diabetes Study, Implications for the care of people with Type 2 diabetes, British Diabetic Association Publication, December 1998.
20. SPSS-X User's guide, second ed., McGraw-Hill, New York, 1998.
21. Gulliford M.C., Mahabir D. A 5 year evaluation of intervention in diabetes care in Trinidad and Tobago. Diab. Med. 16:1999;939-945.
22. Oxman A.D., Thomson M.A., Davis D.A. et al. No magic bullets: a systematic review of 102 trials of intervention to improve professional practice. CMAJ. 153:1995;1423-1431.
23. M.C. Gulliford, C.V. Alert, D. Mahabir, S.M. Ariyanayagam-Baksh, H.S. Fraser, D.I. Picou, Diabetes care in middle-income countries: a Caribbean case study, Diab. Med. 13 (1996) 574-581.
24. K.T. Khaw, E. Barrett-Connor, Sex differences, hormones and coronary heart disease, in: M. Marmot, P. Elliot (Eds.), Coronary Heart Disease From Aetiology to Public Health, Oxford Medical Publ. 1992, pp. 274-286.
25. Ebeling P., Kolvisto V.A. Physiological importance of dehydroepiandrosterone. Lancet. 343:1994;1479-1481.
26. Uusitupa M.I., Niskanen L.K., Siitonen O. et al. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 36:1993;1175-1184.
27. Heyden S., Heiss G., Bartel A.G. et al. Sex differences in coronary mortality among diabetics in Evans County, GA. J. Chronic. Dis. 33:1980;265-271.
28. Jarrett R.J., McCartney P., Keen H. The Bedford survey: 10-year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemie control and risk indices for coronary heart disease on borderline diabetics. Diabetologia. 22:1982;79-84.
29. Orchard T.J., Becker D.J., Kuller L.H. et al. Age and sex variations in glucose tolerance and insulin responses: parallel with cardiovascular risk. J. Chronic. Dis. 35:1982;123-137.
30. Barrett-Connor E., Khaw K.T., Yen S.S.C. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N. Engl. J. Med. 315:1986;1519-1524.
31. Barrett-Connor E., Khaw K.T. Absence of an inverse relation of dehydroeplandrosterone sulfate with cardiovascular mortality in postmenopausal women. N. Engl. J. Med. 317:1987;711.
32. Perneger T.V., Brancati F.L., Whelton P.X. et al. End-stage renal disease attributable to diabetes mellitus. Ann. Intem. Med. 121:1994;912-918.
33. UK Prospective Diabetes Study (UKPDS) XI, Biochemical risk factors in Type 2 diabetic patients at diagnosis compared with aged-matched normal subjects, Diab. Med. 11 (1994) 534-544.
34. Cambien F., Jacqueson A., Richard J.L. et al. Is the level of serum triglyceride a significant predictor of coronary, death in 'cholesterolemic' subjects. The Paris Prospective Study. Am. J. Epidemiol. 124:1986;624-632.
35. Ragoobirsingh D., Davidson J.B. The effect of demographic factors on serum lipids in diabetics of Trinidad and Tobago: possible association with ischaemic heart disease. W. Ind. Med. J. 38:1989;99-104.
36. Miller G.I., Beckles G.L.A., Maude G.H. et al. High density, lipoprotein cholesterol concentration as a predictor of coronary heart disease in West Indian men. J. Epidemiol. Comm. Health. 44(2):1990;136-138.
37. Miller G.J., Kirkwood B.R., Beckles G.L.A. et al. Adult male all-cause cardiovascular and cerebrovascular mortality in relation to ethnic group, systolic blood pressure and blood glucose concentration in Trinidad, West Indies. Int. J. Epidemiol. 17:1988;62-69.
38. Miller G.J., Beckles G.L.A., Alexis S.D. et al. Serum lipoproteins and susceptibility of men of Indian descent to coronary heart disease: The St. James survey, Trinidad. Lancet. 2:1982;200-203.